Predictors of malignant lymph node involvement in patients with mediastinal lymphadenopathy and previous cancer: A cohort study

Keyphrases

• Mediastinal Lymphadenopathy 100%
• Lymph Node Involvement 100%
• Malignant Lymph Node 100%
• Previous Cancer 100%
• Malignancy 50%
• Cancer Diagnosis 50%
• Benign Disease 50%
• Lymphadenopathy 50%
• Sarcoidosis 50%
• Tumor Recurrence 50%
• Previous Malignancy 50%
• Lung Cancer 25%
• Patient Characteristics 25%
• Non-associated 25%
• Clinical High Risk 25%
• Final Diagnosis 25%
• Malignant Disease 25%
• Lymph Node 25%
• Smoking Status 25%
• Bronchoscopy 25%
• Cancer Recurrence 25%
• Enlargement 25%
• Smoking History 25%
• Limited Ability 25%
• Radiographic Predictors 25%
• Retrospective Cohort Analysis 25%
• Clinical Predictors 25%
• Cancer Imaging 25%
• Hilar 25%
• Robotic Bronchoscopy 25%
• Mediastinal Lymph Node Sampling 25%
• Image Dataset 25%
• Positron Emission Tomography/computed Tomography (PET/CT) 25%
• Clinical Decision-making 25%
• Pretest Probability 25%
• Malignancy Diagnosis 25%
• Benign Processes 25%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Cancer 100%
• Cohort Analysis 100%
• Lymph Node 100%
• Mediastinal Lymphadenopathy 100%
• Tumor Recurrence 40%
• Bronchoscopy 40%
• Cancer Diagnosis 40%
• Lymphadenopathy 40%
• Sarcoidosis 40%
• Recurrent Disease 20%
• Lung Cancer 20%
• Final Diagnosis 20%
• Benign Tumor 20%
• Cancer Recurrence 20%
• Positron Emission Tomography-Computed Tomography 20%
• Clinical Decision Making 20%
• Mediastinal Lymph Node 20%
• Endobronchial Ultrasonography 20%
• Diseases 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Cohort Study 100%
• Lymphadenopathy 100%
• Tumor Recurrence 33%
• Sarcoidosis 33%
• Diseases 33%
• Lung Cancer 16%
• Cancer Recurrence 16%
• Recurrent Disease 16%
• Polyethylene Terephthalate 16%